DAVITA INC. Other Selling, General and Administrative Expense
DAVITA INC. (DVA) reported Other Selling, General and Administrative Expense of $25.84 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherSellingGeneralAndAdministrativeExpense · last filed 2020-10-29
- DAVITA INC. other selling, general and administrative expense for the quarter ending 2020-09-30 was $25.84M, a 4.70% increase year-over-year.
- DAVITA INC. other selling, general and administrative expense for the quarter ending 2019-09-30 was $24.68M.
| Period end | Other Selling, General and Administrative Expense 3 month | Other Selling, General and Administrative Expense 9 month |
|---|---|---|
| 2020-09-30 | $25.84M 10-Q · filed 2020-10-29 | $122.51M 10-Q · filed 2020-10-29 |
| 2019-09-30 | $24.68M 10-Q · filed 2020-10-29 | $65.55M 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |